Injection treatment available for reflux in children

Uppsala, Sweden-Q-Med has received FDA approval to market Deflux, a treatmentfor vesicoureteral reflux grades II-IV in children.

Related Content:

Drug Therapy

Oral testosterone undecanoate shows promising results for first use in the real world

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3